Rizatriptan Benzoate Tablet
Product Images NDC 61919-656

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 61919-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

394 (394 18)

This is a product information sheet for a medication called Rizatriptan Benzoate or Maxalt. It comes in 18 tablets, each containing 5mg of rizatriptan benzoate, which is used to treat migraines. The sheet includes some chemical composition information for the medication.*

FDA Label Image

656 12

This is a label of a medication called Rizatriptan Benzoate. The tablets contain 10mg of rizatriptan benzoate USP equivalent to rizatriptan 10mg. The pack comes with 12 tablets, and each tablet contains 14.53mg of rizatriptan. The lot expiry date is 07720.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.